These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15703805)

  • 1. Studies on the 4-benzoylpyridine-3-carboxamide entity as a fragment model of the Isoniazid-NAD adduct.
    Broussy S; Bernardes-Génisson V; Gornitzka H; Bernadou J; Meunier B
    Org Biomol Chem; 2005 Feb; 3(4):666-9. PubMed ID: 15703805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1H and 13C NMR characterization of pyridinium-type isoniazid-NAD adducts as possible inhibitors of InhA reductase of Mycobacterium tuberculosis.
    Broussy S; Bernardes-Génisson V; Coppel Y; Quémard A; Bernadou J; Meunier B
    Org Biomol Chem; 2005 Feb; 3(4):670-3. PubMed ID: 15703806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1H and 13C NMR characterization of hemiamidal isoniazid-NAD(H) adducts as possible inhibitors of InhA reductase of Mycobacterium tuberculosis.
    Broussy S; Coppel Y; Nguyen M; Bernadou J; Meunier B
    Chemistry; 2003 May; 9(9):2034-8. PubMed ID: 12740851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of the tautomeric forms of isoniazid-NAD adducts to the active site of the Mycobacterium tuberculosis enoyl-ACP reductase (InhA): a theoretical approach.
    Stigliani JL; Arnaud P; Delaine T; Bernardes-Génisson V; Meunier B; Bernadou J
    J Mol Graph Model; 2008 Nov; 27(4):536-45. PubMed ID: 18955002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystallographic studies on the binding of isonicotinyl-NAD adduct to wild-type and isoniazid resistant 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis.
    Dias MV; Vasconcelos IB; Prado AM; Fadel V; Basso LA; de Azevedo WF; Santos DS
    J Struct Biol; 2007 Sep; 159(3):369-80. PubMed ID: 17588773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of isoniazid-NAD truncated adducts embedding a lipophilic fragment as potential bi-substrate InhA inhibitors and antimycobacterial agents.
    Delaine T; Bernardes-Génisson V; Quémard A; Constant P; Meunier B; Bernadou J
    Eur J Med Chem; 2010 Oct; 45(10):4554-61. PubMed ID: 20696503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The first chemical synthesis of the core structure of the benzoylhydrazine-NAD adduct, a competitive inhibitor of the Mycobacterium tuberculosis enoyl reductase.
    Broussy S; Bernardes-Génisson V; Quémard A; Meunier B; Bernadou J
    J Org Chem; 2005 Dec; 70(25):10502-10. PubMed ID: 16323864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidating isoniazid resistance using molecular modeling.
    Wahab HA; Choong YS; Ibrahim P; Sadikun A; Scior T
    J Chem Inf Model; 2009 Jan; 49(1):97-107. PubMed ID: 19067649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrogen peroxide-mediated isoniazid activation catalyzed by Mycobacterium tuberculosis catalase-peroxidase (KatG) and its S315T mutant.
    Zhao X; Yu H; Yu S; Wang F; Sacchettini JC; Magliozzo RS
    Biochemistry; 2006 Apr; 45(13):4131-40. PubMed ID: 16566587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of 4-phenoxybenzamide adenine dinucleotide as NAD analogue with inhibitory activity against enoyl-ACP reductase (InhA) of Mycobacterium tuberculosis.
    Bonnac L; Gao GY; Chen L; Felczak K; Bennett EM; Xu H; Kim T; Liu N; Oh H; Tonge PJ; Pankiewicz KW
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4588-91. PubMed ID: 17560106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of the isonicotinoylnicotinamide scaffolds of the naturally occurring isoniazid-NAD(P) adducts.
    Delaine T; Bernardes-Génisson V; Meunier B; Bernadou J
    J Org Chem; 2007 Jan; 72(2):675-8. PubMed ID: 17221997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural adaptation of an interacting non-native C-terminal helical extension revealed in the crystal structure of NAD+ synthetase from Bacillus anthracis.
    McDonald HM; Pruett PS; Deivanayagam C; Protasevich II; Carson WM; DeLucas LJ; Brouillette WJ; Brouillette CG
    Acta Crystallogr D Biol Crystallogr; 2007 Aug; 63(Pt 8):891-905. PubMed ID: 17642516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural study of ribonucleotide reductase inhibitor hydrazones. Synthesis and X-ray diffraction analysis of a copper(II)-benzoylpyridine-2-quinolinyl hydrazone complex.
    Tamasi G; Chiasserini L; Savini L; Sega A; Cini R
    J Inorg Biochem; 2005 Jun; 99(6):1347-59. PubMed ID: 15869799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amide-N-oxide heterosynthon and amide dimer homosynthon in cocrystals of carboxamide drugs and pyridine N-oxides.
    Babu NJ; Reddy LS; Nangia A
    Mol Pharm; 2007; 4(3):417-34. PubMed ID: 17497888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystallographic and pre-steady-state kinetics studies on binding of NADH to wild-type and isoniazid-resistant enoyl-ACP(CoA) reductase enzymes from Mycobacterium tuberculosis.
    Oliveira JS; Pereira JH; Canduri F; Rodrigues NC; de Souza ON; de Azevedo WF; Basso LA; Santos DS
    J Mol Biol; 2006 Jun; 359(3):646-66. PubMed ID: 16647717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and kinetic properties of a beta-hydroxyacid dehydrogenase involved in nicotinate fermentation.
    Reitz S; Alhapel A; Essen LO; Pierik AJ
    J Mol Biol; 2008 Oct; 382(3):802-11. PubMed ID: 18680749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-Cyanobenzaldehyde isonicotinoylhydrazone monohydrate: a three-dimensional hydrogen-bonded framework structure.
    Souza MV; Wardell SM; Wardell JL; Low JN; Glidewell C
    Acta Crystallogr C; 2007 Mar; 63(Pt 3):o166-8. PubMed ID: 17339722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid.
    Vilchèze C; Wang F; Arai M; Hazbón MH; Colangeli R; Kremer L; Weisbrod TR; Alland D; Sacchettini JC; Jacobs WR
    Nat Med; 2006 Sep; 12(9):1027-9. PubMed ID: 16906155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the sirtuin mechanism from ternary complexes containing NAD+ and acetylated peptide.
    Hoff KG; Avalos JL; Sens K; Wolberger C
    Structure; 2006 Aug; 14(8):1231-40. PubMed ID: 16905097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of large macrocyclic azacalix[n]pyridines (n = 6 - 9) and their complexation with fullerenes C(60) and C(70).
    Zhang EX; Wang DX; Zheng QY; Wang MX
    Org Lett; 2008 Jun; 10(12):2565-8. PubMed ID: 18484735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.